Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saussurea costus root extract is a botanical preparation derived from the roots of the Himalayan medicinal plant *Saussurea costus* (also known as *Dolomiaea costus*). The extract contains bioactive sesquiterpene lactones, primarily costunolide and dehydrocostus lactone, which exhibit potent anti-neoplastic, anti-inflammatory, and antioxidant activities. In preclinical models of breast cancer, the extract has demonstrated the ability to inhibit tumor growth by suppressing pro-inflammatory signaling pathways (NF-κB and TNF-α), reducing cellular proliferation markers (Ki-67 and PCNA), and inhibiting metastasis (MMP-9) and neovascularization (VEGF). Furthermore, it induces apoptosis through the modulation of the p53/Bax/Bcl-2 axis and activation of caspase-3. Traditionally used in Ayurvedic and Unani medicine, it is also investigated for its potential to mitigate oxidative stress and protect liver and kidney function during oncological treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saussurea costus root extract.